GMP (Good Manufacturing Practice)
A system of regulations ensuring that products are consistently produced and controlled according to quality standards. Required for pharmaceutical-grade cannabinoid products.
In Depth
GMP compliance is required for any cannabinoid product used in FDA-regulated clinical trials or sold as a pharmaceutical. GMP standards cover facility design, equipment qualification, raw material testing, in-process controls, finished product testing, and documentation. Most commercial CBD products are not manufactured under GMP conditions, contributing to the significant discrepancy between labeled and actual cannabinoid content found in independent testing studies.
Related Terms
More in Regulatory
Schedule I
The most restrictive classification under the US Controlled Substances Act (CSA), applied to substances deemed to have high abuse potential, no accepted medical use, and lack of accepted safety under medical supervision.
IND (Investigational New Drug)
An application submitted to the FDA allowing a pharmaceutical company or researcher to begin clinical trials of an unapproved drug in humans.
NCT Number
A unique identifier assigned by ClinicalTrials.gov to every registered clinical study. Format: NCT followed by 8 digits (e.g., NCT04849910).